X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8405) 8405
Publication (529) 529
Newsletter (259) 259
Book Review (110) 110
Magazine Article (25) 25
Transcript (24) 24
Book / eBook (15) 15
Book Chapter (10) 10
Dissertation (7) 7
Newspaper Article (5) 5
Conference Proceeding (3) 3
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5873) 5873
male (4443) 4443
anti-arrhythmia agents - therapeutic use (3632) 3632
female (3446) 3446
animals (2851) 2851
anti-arrhythmia agents - pharmacology (2275) 2275
middle aged (2268) 2268
index medicus (2175) 2175
cardiac & cardiovascular systems (2118) 2118
aged (2057) 2057
electrocardiography (1668) 1668
adult (1592) 1592
anti-arrhythmia agents - administration & dosage (1415) 1415
pharmacology & pharmacy (1411) 1411
anti-arrhythmia agents - adverse effects (1319) 1319
heart rate - drug effects (1277) 1277
anti-arrhythmia drugs (1150) 1150
atrial fibrillation (1100) 1100
blood pressure - drug effects (1037) 1037
arrhythmias, cardiac - drug therapy (996) 996
rats (977) 977
treatment outcome (955) 955
dogs (934) 934
anti-arrhythmia agents - blood (922) 922
atrial fibrillation - drug therapy (900) 900
time factors (764) 764
arrhythmia (720) 720
amiodarone (713) 713
dose-response relationship, drug (702) 702
heart (603) 603
anti-arrhythmia agents - pharmacokinetics (594) 594
cardiac arrhythmia (591) 591
risk factors (589) 589
anti-arrhythmia agents (543) 543
arrhythmias (537) 537
amiodarone - therapeutic use (507) 507
care and treatment (505) 505
drug therapy (499) 499
heart - drug effects (489) 489
atrial fibrillation - physiopathology (485) 485
cardiology (483) 483
hemodynamics - drug effects (482) 482
amiodarone - adverse effects (477) 477
aged, 80 and over (476) 476
analysis (474) 474
arrhythmias, cardiac - physiopathology (471) 471
electrophysiology (458) 458
tachycardia (429) 429
mortality (425) 425
in vitro techniques (422) 422
heart conduction system - drug effects (412) 412
research (409) 409
medicine & public health (406) 406
heart failure (397) 397
heart rate (394) 394
follow-up studies (389) 389
cardiovascular (388) 388
administration, oral (386) 386
prospective studies (379) 379
therapy (378) 378
medicine, general & internal (369) 369
atrial fibrillation - therapy (360) 360
prevention (354) 354
drug interactions (353) 353
drugs (353) 353
arrhythmias, cardiac - etiology (350) 350
injections, intravenous (350) 350
adrenergic beta-antagonists - therapeutic use (347) 347
tachycardia - drug therapy (340) 340
infusions, intravenous (332) 332
management (330) 330
electrocardiography - drug effects (329) 329
rabbits (329) 329
adolescent (326) 326
disease models, animal (322) 322
electric countershock (320) 320
amiodarone - administration & dosage (310) 310
ischemia (305) 305
rats, sprague-dawley (299) 299
catheter ablation (298) 298
sinus rhythm (298) 298
abridged index medicus (297) 297
retrospective studies (296) 296
arrhythmias, cardiac - chemically induced (295) 295
pharmacokinetics (295) 295
flecainide (290) 290
cardiac patients (289) 289
health aspects (289) 289
myocardial contraction - drug effects (289) 289
surgery (289) 289
double-blind method (280) 280
drug therapy, combination (278) 278
action potentials - drug effects (274) 274
recurrence (274) 274
efficacy (269) 269
peripheral vascular disease (268) 268
risk (267) 267
cardiac pacing, artificial (262) 262
clinical trials as topic (262) 262
blood pressure (261) 261
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8124) 8124
German (157) 157
Russian (142) 142
French (75) 75
Japanese (69) 69
Chinese (44) 44
Italian (32) 32
Spanish (30) 30
Polish (23) 23
Norwegian (6) 6
Portuguese (5) 5
Hungarian (4) 4
Swedish (4) 4
Czech (3) 3
Dutch (3) 3
Slovak (3) 3
Hebrew (2) 2
Serbian (2) 2
Turkish (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Danish (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 105 - 114
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2268 - 2276
Patients with permanent atrial fibrillation and additional cardiac risk factors were randomly assigned to receive either dronedarone or placebo. At a median of... 
HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Risk groups | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 10, pp. 1063 - 1074
Digoxin is widely used in patients with atrial fibrillation (AF). The goal of this paper was to explore whether digoxin use was independently associated with... 
mortality | heart failure | atrial fibrillation | digoxin | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | HEART-FAILURE | APIXABAN | ALL-CAUSE MORTALITY | STROKE | TRIAL | REDUCTION | THROMBOEMBOLIC EVENTS | OUTCOMES | RISK-ASSESSMENT | Risk Assessment - methods | Digoxin - adverse effects | Outcome Assessment (Health Care) | Correlation of Data | Humans | Middle Aged | Anti-Arrhythmia Agents - blood | Male | Cause of Death | Risk Assessment - statistics & numerical data | Atrial Fibrillation - mortality | Female | Heart Failure - diagnosis | Atrial Fibrillation - diagnosis | Digoxin - blood | Heart Failure - mortality | Death, Sudden - epidemiology | Death, Sudden - etiology | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - pharmacokinetics | Anti-Arrhythmia Agents - administration & dosage | Digoxin - pharmacokinetics | Digoxin - administration & dosage | Anti-Arrhythmia Agents - adverse effects | Aged | Heart | Digoxin | Atrial fibrillation | Patient outcomes | Analysis | Mortality | Cardiac patients | Heart failure | Cardiac arrhythmia | Peptides | Embolisms | Systematic review | Patients | Fibrillation | Health hazards | Biomarkers | Death | Risk management | Thromboembolism | Cardiology | Drug therapy | Heart diseases | Drug dosages | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 09/2017, Volume 106, Issue 9, pp. 2758 - 2770
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 11/2009, Volume 297, Issue 5, pp. 1923 - 1929
We tested the effect of the antianginal agent ranolazine on ventricular arrhythmias in an ischemic model using two protocols. In protocol 1, anesthetized rats... 
Ventricular tachycardia | Myocardial ischemia-reperfusion | Arrhythmias | Ranolazine | Ventricular fibrillation | ventricular fibrillation | LATE SODIUM CURRENT | CONTROLLED-TRIAL | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | RAT | myocardial ischemia-reperfusion | PATHOPHYSIOLOGY | arrhythmias | ventricular tachycardia | CHANNEL | ANGINA-PECTORIS | ranolazine | PERIPHERAL VASCULAR DISEASE | HYDROGEN-PEROXIDE | DYSFUNCTION | INHIBITOR | ISCHEMIA/REPERFUSION | Piperazines - administration & dosage | Injections, Intravenous | Acetanilides - administration & dosage | Myocardial Reperfusion Injury - complications | Anti-Arrhythmia Agents - pharmacology | Anti-Arrhythmia Agents - blood | Male | Ventricular Fibrillation - etiology | Dose-Response Relationship, Drug | Heart Rate - drug effects | Time Factors | Electrocardiography | Myocardial Ischemia - physiopathology | Ventricular Fibrillation - physiopathology | Female | Blood Pressure - drug effects | Myocardial Reperfusion Injury - drug therapy | Piperazines - blood | Disease Models, Animal | Ventricular Fibrillation - prevention & control | Acetanilides - pharmacology | Tachycardia, Ventricular - etiology | Angina Pectoris - drug therapy | Rats | Tachycardia, Ventricular - prevention & control | Anti-Arrhythmia Agents - administration & dosage | Myocardial Ischemia - drug therapy | Piperazines - pharmacology | Rats, Sprague-Dawley | Myocardial Reperfusion Injury - physiopathology | Tachycardia, Ventricular - physiopathology | Animals | Myocardial Ischemia - complications | Acetanilides - blood | Infusions, Intravenous | Care and treatment | Development and progression | Myocardial ischemia | Dosage and administration | Research
Journal Article
Circulation: Arrhythmia and Electrophysiology, ISSN 1941-3149, 12/2014, Volume 7, Issue 6, pp. 1019 - 1025
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 09/2017, Volume 106, Issue 9, pp. 2826 - 2838
The use of – extrapolation (IVIVE) techniques, mechanistically incorporated within physiologically based pharmacokinetic (PBPK) models, can harness drug data... 
clearance | physiological model | distribution | absorption | preclinical pharmacokinetics | simulations | CHEMISTRY, MEDICINAL | VIVO | INTERINDIVIDUAL VARIABILITY | IN-VITRO DATA | DRUG DISCOVERY | PLASMA PARTITION-COEFFICIENTS | CHEMISTRY, MULTIDISCIPLINARY | PREDICTION | TISSUE DISTRIBUTION | LABORATORY-ANIMALS | PHARMACOLOGY & PHARMACY | INDUSTRY PERSPECTIVE | Adjuvants, Anesthesia - administration & dosage | Diazepam - metabolism | Anti-Arrhythmia Agents - blood | Midazolam - administration & dosage | Anticonvulsants - administration & dosage | Male | Metabolic Clearance Rate | Anti-Arrhythmia Agents - metabolism | Hepatocytes - metabolism | Diazepam - pharmacokinetics | Adjuvants, Anesthesia - pharmacokinetics | Computer Simulation | Adjuvants, Anesthesia - metabolism | Metoprolol - metabolism | Metoprolol - blood | Adjuvants, Anesthesia - blood | Anticonvulsants - blood | Anticonvulsants - pharmacokinetics | Diazepam - administration & dosage | Anticonvulsants - metabolism | Metoprolol - administration & dosage | Anti-Arrhythmia Agents - pharmacokinetics | Midazolam - pharmacokinetics | Anti-Arrhythmia Agents - administration & dosage | Rats, Sprague-Dawley | Metoprolol - pharmacokinetics | Administration, Intravenous | Animals | Midazolam - blood | Models, Biological | Diazepam - blood | Midazolam - metabolism
Journal Article